Nachrichten zur Moderna Inc. Aktie

Moderna Earnings Hit by Falling Covid Vaccine Sales. Stock Slides.

Shares of the biotech company fell early Thursday, wiping out gains from positive news around its cancer vaccine candidate, as…

UPDATE 2-Moderna reaffirms 2023 COVID vaccine sales forecast of $5 billion

...(Adds details on fourth-quarter sales) Feb 23 (Reuters) - Moderna Inc......…

Moderna reaffirms 2023 COVID vaccine sales forecast of $5 billion

...(Reuters) -Moderna Inc reaffirmed its annual sales forecast of $5......…

NASDAQ-Wert Moderna-Aktie vorbörslich im Minus: Moderna steigert Umsatz 2022

Am Donnerstag hat das Biotech-Unternehmen Moderna über die Ergebnisse zum vierten Quartal 2022 sowie zum gesamten Fiskaljahr 2022 informiert....…

Moderna earnings fall short of estimates amid steep decline in COVID vaccine sales, expects to file for approval of RSV vaccine in first half

Moderna Inc. MRNA said Thursday it had net income of $1.465 billion, or $3.61 a share, in the fourth quarter,…

Moderna forecasts 2023 COVID vaccine sales below market expectations

...Feb 23 (Reuters) - Moderna Inc on Thursday reiterated its forecast......…

Moderna, Inc.: Moderna Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Updates

Fourth quarter 2022 revenues of $5.1 billion; GAAP net income of $1.5 billion and GAAP diluted EPS of $3.61Full-year 2022…

Moderna GAAP EPS of $3.61 misses by $1.14, revenue of $5.1B beats by $80M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

DAX: Deutsche Telekom, SAP, Munich Re, Hensoldt, Moderna, Nvidia und SFC Energy im Fokus – das ist heute wichtig

Der DAX dürfte am Donnerstag etwas höher starten. Der Broker IG taxiert den deutschen Leitindex rund zweieinhalb Stunden vor dem…

Idaho Lawmakers Seek To Criminalize Injecting Of mRNA COVID-19 Vaccines

Idaho Lawmakers Seek To Criminalize Injecting Of mRNA COVID-19 Vaccines …

Moderna, Merck receives FDA breakthrough status for personalized cancer vaccine

CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Merck and Moderna receiving FDA breakthrough status for a personalized…

Stocks making the biggest moves after hours: Nvidia, Etsy, Lucid, Bumble, Moderna and more

These are the stocks posting the largest moves in extended hours trading....…

Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation

Moderna Inc. MRNAand Merck Inc. MRK shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine…

Moderna, Inc.: Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, in Combination With KEYTRUDA , was Granted Breakthrough Therapy Designation by the FDA for Adjuvant Treatment of Patients With High-Risk Me

Designation based on positive data from Phase 2b KEYNOTE-942/mRNA-4157-P201 trialCAMBRIDGE, MA and RAHWAY, NJ / ACCESSWIRE / February 22, 2023…

Moderna Hopes To Build On mRNA Tech Used In Its Covid Shots—By Targeting Genetic Diseases

Moderna announced a partnership with Life Edit Therapeutics to tackle “some of the most challenging genetic diseases” using its mRNA…

UPDATE 1-Moderna enters R&D collaboration for mRNA gene-editing therapies

...(Adds details on collaboration) Feb 22 (Reuters) - Moderna Inc......…

Moderna enters R&D collaboration for mRNA gene-editing therapies

...(Reuters) - Moderna Inc said on Wednesday it had entered......…

Moderna to collaborate with Life Edit on gene editing therapies

Moderna Inc. MRNA announced Wednesday a collaboration agreement with privately held Life Edit Therapeutics Inc. to discover and develop in…

Moderna Inc. stock falls Tuesday, underperforms market

Moderna Inc. stock falls Tuesday, underperforms market...…

Moderna favored at Morgan Stanley on U.S. support for Arbutus patent case

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Where Will Moderna Be in 5 Years?

Moderna shares have what it takes to gain over time....…

Walmart, Alibaba, Moderna, and More to Watch

Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home…

Walmart, Alibaba, Moderna, and More to Watch This Week

Home Depot, Lucid, TJX, and others also report earnings. Investors will see Fed minutes and economic data on manufacturing, home…

US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit

US Says Government, Not Moderna, Should Face COVID-19 Vaccine Lawsuit …

Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen

Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…

Moderna Inc. stock underperforms Friday when compared to competitors

Moderna Inc. stock underperforms Friday when compared to competitors...…

Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more

Deere shares popped on strong earnings....…

Moderna Omicron booster cleared in Canada for children and adolescents

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds

Moderna: Health Canada Authorizes Omicron-Targeting Vaccine in 6-to-17-Year-Olds...…

Dow Jones, S&P 500, Nasdaq: Inflationssorgen lasten auf US-Börsen – Moderna-Aktie gerät unter Druck

Die Experten von Goldman Sachs erwarten mittlerweile sogar drei weitere Zinsschritte in den USA. Die wichtigsten Indizes liegen zunächst im…

Moderna: Die Pipeline verbessert sich - Kaufen! Aktienanalyse

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co: Die Analysten von Jefferies & Co stufen die Aktie von Moderna Inc.…

Moderna: Daten zum Grippeimpfstoff-Kandidaten fallen gemischt aus - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Marion Schlegel vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Moderna Inc. (ISIN: US60770K1079,…

Moderna Stock Falls as Study of Flu Vaccine Has Mixed Results

The shot got a strong immune response, but wasn't shown to be more effective than other vaccines....…

Coronavirus tally: Moderna flu vaccine trial falls short on one goal, sending stock down

Moderna Inc. stock was down 6.6% premarket Friday, after the COVID vaccine maker said a trial of a flu…

BioNTech-Konkurrent Moderna: Nur gemischte Daten bei Grippe-Impfstoff – Aktie unter Druck

Das US-Biotech-Unternehmen Moderna hat am Donnerstag nur gemischte Daten zu seinem Grippeimpfstoff-Kandidaten mRNA-1010 vorgelegt. Dies berichtet die Nachrichtenagentur Bloomberg....…

Moderna Buy

NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat die Einstufung für Moderna nach Studiendaten zum Influenza-Impfstoff mRNA-1010 auf…

Moderna stock falls on mixed results of flu vaccine mRNA-1010 in phase 3 trial

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

DoorDash, DraftKings, Moderna, Redfin, and More Stock Market Movers

Fourth-quarter revenue at DoorDash rises 40%, and DraftKings boosts its guidance for fiscal 2023....…

Stocks to Watch: iBio, DoorDash, DraftKings, Moderna

Stocks to Watch: iBio, DoorDash, DraftKings, Moderna...…

After-Hours Alert: Why Moderna Stock Is Diving

Moderna Inc (NASDAQ: MRNA) shares are trading lower in Thursday's after-hours session after the company released interim Phase 3 safety and…

UPDATE 1-Moderna flu vaccine delivers mixed results in trial, shares fall

... Erman Feb 16 (Reuters) - Moderna Inc on Thursday said its closely......…

Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study

Moderna Shares Fall 5.9% on Mixed Results From Flu Shot Study...…

Moderna Flu Shot Gives Mixed Immune Results in Final-Stage Trial

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Moderna stock falls 5% after flu vaccine study results

Moderna Inc. shares dove more than 5% in after-hours trading Thursday, after the company announced that a study into a…

Moderna, Inc.: Moderna Announces Interim Phase 3 Safety and Immunogenicity Results for mRNA-1010, a Seasonal Influenza Vaccine Candidate

mRNA-1010 demonstrated superiority on seroconversion rates for A/H3N2 and A/H1N1, superiority on geometric mean titer ratios for A/H3N2, and non-inferiority…

dpa-AFX ProFeed